Skip to main content
. 2021 Aug 30;12:29. doi: 10.1007/s12672-021-00425-6

Fig. 6.

Fig. 6

BI853520 increases biologic effects combined with chemotherapy. A, B Cell viability was assessed following treatment with 10 μM of BI853520 in combination with paclitaxel for 72 h with a range of concentrations. C, D Cell viability was assessed following treatment with 10 μM of BI853520 in combination with cisplatin for 96 h with a range of concentrations. The data were presented as mean ± SD of three independent experiments. **P < 0.01